Welcome to our new Web site! We’ve added some new Web features that we think you’ll like. Features that will help you manage your psoriasis and/or psoriatic arthritis, connect with others and be a part of the movement to find a cure. To access all our new site offers, please login or create an online account.
 
     
 
National Psoriasis Foundation Newsfeed
Psoriasis Foundation CEO joins CEOs of 47 leading health organizations calling on Congress to reform health care.


Unexpected Bacterial Diversity On Human Skin; New Approaches For Treating, Preventing Skin Diseases


New guidelines for the management of psoriasis


New excimer laser enables psoriasis and vitiligo treatments three times faster


Making awareness contagious


Psoralen and UVA light therapy (PUVA) for psoriasis


FDA extends review on J&J psoriasis drug candidate - News Wires - CNBC.com


Dermatologists Release Psoriasis Care Guidelines


Five scientists each receive $50,000 from National Psoriasis Foundation for promising research


Isotechnika Inc. Announces Phase 3 ESSENCE Data Meets Primary Endpoint in Psoriasis


SIMPONI (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis


Psoriasis Associated With Diabetes And High Blood Pressure In Women


Health Canada Approves Centocor Ortho Biotech Inc. and Schering-Plough Corporation (SGP)'s SIMPONI(TM) for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis; First World Regulatory Approval for SIMPONI


National Psoriasis Foundation statement on Genentech withdrawing Raptiva


Genentech Announces Voluntary Withdrawal of Raptiva from the U.S. Market


Investigational Anti-TNF Biologic Modestly Helpful in Psoriatic Arthritis


Genetic 'master regulator' in skin formation identified


Psoriasis may reflect systemic inflammation, heart disease


Unraveling psoriasis at a genetic level


AAD: Anti-TNF Therapy Improves Psoriasis and Psoriatic Arthritis


Terri Theisen elected to National Psoriasis Foundation Board of Trustees


Need advocacy for psoriasis research


Low-Dose Acitretin Shown Effective in Nail Psoriasis


New Laser for Psoriasis Aims to Cut Treatment


LeAnn Rimes shares her personal struggle with psoriasis in nation's capital


Congress takes on nation's most prevalent autoimmune disease


Tim Gunn’s Fashion Therapy for Psoriasis


Dermatologists Caution That Severe Cases of Psoriasis Can be Associated with Other Serious Medical Conditions


National Psoriasis Foundation launches new mission statement


"Project Runway's" Tim Gunn launches Addressing Psoriasis™ campaign to advocate that patients shouldn't let psoriasis impact personal style


American Academy of Dermatology Issues New Guidelines for the Management of Psoriasis with Topical Therapies


Raptiva may cause serious side effects


FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva


Anacor Announces Positive Results from Phase 2 Psoriasis Trial


Ustekinumab improves psoriatic arthritis, study says


Drug Reduces Inflammatory Arthritis Symptoms, Lesions


Letter to the editor: More need access to psoriasis treatments


Academy of Country Music and The Home Depot(R) Select Country Music Artist Leann Rimes to Receive Humanitarian Award


Your Views


New genetic markers of psoriasis revealed


Psoriasis and Psoriatic Arthritis Research Cure and Care Act reintroduced in the U.S. House of Representatives


National Psoriasis Foundation submits letter to President Obama


Progress continues to be made on insurance coverage for patients


Galderma Laboratories Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis


National Psoriasis Foundation asks President Obama to reform harmful and discriminatory health insurance practices


Erythrodermic Psoriasis - Live Webcast Tuesday, Feb. 3


Promius Pharma, LLC Launches Scytera? (Coal Tar) Foam 2% for Treatment of Psoriasis


Scientists Unmask Genetic Markers Associated With Psoriasis


Virtual communities may provide valuable support for psoriasis patients


High copayments limit treatment options for psoriasis patients


 

Share